Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose in RLS with Iron-deficiency Anemia
NCT02826681Phase 2Terminated
- Sponsor
- American Regent, Inc.
- Start
- Jul 2017
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in restless legs syndrome (RLS), sponsored by American Regent, Inc.. Started Jul 2017; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02826681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826681.